首頁 > 市場調查報告書 > 醫療設備

纖維

市場調查報告書

商品編碼

1900248

生物醫用紡織品市場規模、佔有率和成長分析（按纖維類型、織物類型、產品類型、應用和地區分類）－2026-2033年產業預測

Biomedical Textiles Market Size, Share, and Growth Analysis, By Fiber Type (Non-Biodegradable, Biodegradable), By Fabric Type (Woven, Non-Woven), By Product Type, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，生物醫學紡織品市場規模將達到 189.2 億美元，到 2025 年將達到 201.9 億美元，到 2033 年將達到 339.1 億美元，在預測期（2026-2033 年）內複合年成長率為 6.7%。

由於人們對醫療技術進步的認知不斷提高，以及對醫用服裝的需求日益成長，生物醫用紡織品市場正經歷著顯著成長。推動市場發展的關鍵因素包括人造牙齒、身體增強解決方案和人工植牙等醫療矯正器具的日益普及。人口老化加劇也對市場產生影響，尤其體現在膝關節關節重建手術數量的增加以及由此帶來的植入需求成長。此外，對OK繃、紗布等創傷護理產品以及整形外科植入的需求不斷成長，也推動了市場發展。其他因素還包括慢性病發病率上升、都市化進程加快、發展中地區醫療保健成本不斷上漲，以及生活方式的改變和可支配收入的增加。

生物醫用紡織品市場促進因素

由於醫療專業人員擴大採用生物醫用服裝來修復或取代受損的身體部位，生物醫用紡織品市場正在蓬勃發展。這些創新纖維被廣泛應用於各種領域，包括合成組織、纖維和移植材料，從而顯著推動了醫療程序的進步。例如，合成纖維植入可以作為人工動脈和血管，有效解決心血管系統的阻塞和薄弱環節。此外，醫用級纖維在各種整形外科應用中也至關重要，例如縫線、關節和肌腱移植、重組裝置以及脊椎敷料，這些都顯著改善了患者的治療效果和復原過程。

生物醫用紡織品市場的限制因素

生物醫用紡織品市場面臨許多挑戰，可能阻礙其發展。開發這些專為抵禦各種健康威脅而設計的尖端材料需要大量的研發投入和相關成本。勞動力、技術專長和其他生產要素的高昂成本可能構成重大障礙。此外，使用聚酯、棉、聚丙烯、聚氨酯和乙烯基等合成材料增加了製造流程的複雜性，並需要大量投資，這可能會阻礙新進入者進入市場。這些資金限制最終可能會限制創新和專業生物醫用紡織品的擴張。

生物醫用紡織品市場趨勢

受對先進醫療解決方案日益成長的需求驅動，生物醫用紡織品市場正經歷顯著成長。醫療保健服務的擴展和醫學素養的提高，為生物製藥和醫用紡織品領域的創新創造了有利環境。意外事故、文明病和感染疾病的發生率上升，進一步凸顯了對能夠提高患者照護和治療效率的先進醫用紡織品的需求。為了應對這些挑戰，並隨著醫療保健預算的不斷增加，製造商正利用生物醫用紡織品領域的技術進步，在不斷變化的醫療產業格局中佔據戰略優勢。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Royal DSM（Netherlands）
Johnson & Johnson（United States）
Medtronic（United States）
Cardinal Health（United States）
Integra LifeSciences Corporation（United States）
Smith & Nephew（United Kingdom）
Medline（United States）
Paul Hartmann AG（Germany）
BSN Medical（Germany）
ATEX Technologies（United States）
Elkem Silicones（Germany）
Bally Ribbon Mills（United States）
US Biodesign（United States）
Nitto Denko Corporation（Japan）
Kimberly-Clark（United States）
Molnlycke Health Care（Sweden）
3M Company（United States）
Ahlstrom-Munksjo（Sweden）
Freudenberg & Co. Kommanditgesellschaft（Germany）
Secant Group LLC（United States）

結論與建議

簡介目錄

Product Code: SQMIG15A2431

Biomedical Textiles Market size was valued at USD 18.92 Billion in 2024 and is poised to grow from USD 20.19 Billion in 2025 to USD 33.91 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The biomedical textiles market is experiencing significant growth due to heightened awareness of healthcare advancements and the demand for medically suitable apparel. Key market drivers include a rising prevalence of medical dressings, such as artificial teeth, body augmentation solutions, and dental implants. The expansion of the geriatric population is also influencing the market, particularly as it correlates with an uptick in knee joint replacement surgeries and the subsequent demand for implants. Additionally, the soaring need for wound care products like plasters and gauze, alongside orthopedic implants, is propelling market development. Other contributing factors include an increase in chronic conditions, urbanization, and rising healthcare costs in developing regions, combined with changing lifestyles and growing disposable incomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biomedical Textiles market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biomedical Textiles Market Segments Analysis

Global Biomedical Textiles Market is segmented by Fiber Type, Fabric Type, Product Type, Application and region. Based on Fiber Type, the market is segmented into Non-Biodegradable and Biodegradable. Based on Fabric Type, the market is segmented into Woven and Non-Woven. Based on Product Type, the market is segmented into Non-Implantable and Implantable. Based on Application, the market is segmented into Dentistry, General Surgery & Treatment, Ophthalmology, Neurology, Cardiology, Orthopedics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biomedical Textiles Market

The Biomedical Textiles market is experiencing growth due to the rising adoption of biomedical garments by healthcare professionals for enhancing and replacing damaged body parts. These innovative textiles have a wide-ranging application in synthetic tissues, fibers, and grafts, enabling significant advancements in medical procedures. For instance, synthetic fabric implants serve as artificial arteries or vessels, effectively addressing blockages or weaknesses in the cardiovascular system. Additionally, pharmaceutical textiles are essential in various orthopedic applications, including sutures, joint and tendon grafts, reconstructive devices, and spinal dressings, thereby significantly improving patient outcomes and recovery processes in the healthcare sector.

Restraints in the Biomedical Textiles Market

The Biomedical Textiles market faces several challenges that can hinder its growth. The extensive research and development necessary for creating these advanced materials, which are specifically engineered to resist various health-related threats, incurs significant costs. The high expenses associated with labor, technical expertise, and other production factors can be a substantial barrier. Furthermore, the use of synthetic materials like polyester, cotton, polypropylene, polyurethane, and vinyl adds complexity to the manufacturing process, requiring large investments that may deter potential entrants to the market. These financial constraints can ultimately limit innovation and the expansion of specialized biomedical textile products.

Market Trends of the Biomedical Textiles Market

The Biomedical Textiles market is experiencing significant growth driven by the rising demand for advanced healthcare solutions. The expansion of healthcare services, coupled with heightened healthcare literacy, is fostering an environment conducive to innovation in biopharmaceuticals and medical textiles. Increasing rates of accidents, lifestyle-related diseases, and infectious conditions further amplify the need for sophisticated medical textiles that enhance patient care and procedural effectiveness. As healthcare budgets continue to rise, manufacturers are poised to leverage technological advancements in biomedical textiles to address these challenges, positioning themselves strategically within the evolving landscape of the healthcare industry.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global Biomedical Textiles Market Size by Fiber Type & CAGR (2026-2033)

Market Overview
Non-Biodegradable
Biodegradable

Global Biomedical Textiles Market Size by Fabric Type & CAGR (2026-2033)

Market Overview
Woven
Non-Woven

Global Biomedical Textiles Market Size by Product Type & CAGR (2026-2033)

Market Overview
Non-Implantable
Implantable

Global Biomedical Textiles Market Size by Application & CAGR (2026-2033)

Market Overview
Dentistry
General Surgery & Treatment
Ophthalmology
Neurology
Cardiology
Orthopedics
Others

Global Biomedical Textiles Market Size & CAGR (2026-2033)

North America (Fiber Type, Fabric Type, Product Type, Application)
- US
- Canada
Europe (Fiber Type, Fabric Type, Product Type, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Fiber Type, Fabric Type, Product Type, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Fiber Type, Fabric Type, Product Type, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Fiber Type, Fabric Type, Product Type, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Royal DSM (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Paul Hartmann AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BSN Medical (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATEX Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elkem Silicones (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bally Ribbon Mills (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
US Biodesign (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nitto Denko Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kimberly-Clark (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molnlycke Health Care (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ahlstrom-Munksjo (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Freudenberg & Co. Kommanditgesellschaft (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Secant Group LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments